Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,060

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,786

Class I recallsReasonable probability of serious health consequences

24,313

Class II recallsTemporary or medically reversible health consequences

2,876

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/freshpoint-issues-recall-due-improperly-declared-allergen-egg-chicken-salad-wedge-sandwichesPublished September 8, 2026

Most affected stateHawaii 200 recalls mention this state

State: AS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 9, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

FDA Recall Ongoing Historical recordClass III

Diphenhydramine HCl 50 mg, 1000 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc. 373 Route US 46, Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8026-02.

by Akron Pharma, Inc.

Reason: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Published: January 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2.

by Akron Pharma, Inc.

Reason: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Published: January 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Diphenhydramine HCl 25 mg, 100 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8028-1.

by Akron Pharma, Inc.

Reason: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Published: January 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Acetaminophen Extra Strength 500 mg, 1000 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., 373 US RT 46 W Building E, Suite 117, Fairfield, NJ 07034, NDC 71399-8022-02

by Akron Pharma, Inc.

Reason: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Published: January 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-8014-01.

by Akron Pharma, Inc.

Reason: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Published: January 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .

by Akron Pharma, Inc.

Reason: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Published: January 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Acetaminophen Extra Strength 500 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8022-01.

by Akron Pharma, Inc.

Reason: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Published: January 22, 2025
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

Eclectic Institute Inc

Product: Eclectic Herb Vitamin Herb Blend vita biotic dietary supplem…
Reason: Product's ingredients names such as Oregon Grape, Cayenne Root, and Ginger Fruit and their quantities were not listed correctly in the Supplement Facts panel.
Published: January 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60

by Rising Pharma Holding, Inc.

Reason: CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection, 10 mL Multi-Dose Reaction Vial, 5 vial Box, Rx Only, Manufactured for: Jubilant Draximage Inc., dba Jubilant Radiopharma, Kirkland , Quebec, H9H, 4J$, Canada, NDC# 65174-179-05.

by Jubilant Draximage Inc., dba Jubilant Radiopharma

Reason: Failed Stability Specifications
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ

by Rising Pharma Holding, Inc.

Reason: CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ

by Rising Pharma Holding, Inc.

Reason: CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03

by Granules Pharmaceuticals Inc.

Reason: Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10

by Eugia US LLC

Reason: Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India

by Eugia US LLC

Reason: CGMP Deviations
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-423-21

by Amerisource Health Services LLC

Reason: Presence of Foreign Tablets/Capsules
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0709-20

by West-Ward Columbus Inc

Reason: Failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05

by FDC Limited

Reason: Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

Clonazepam Orally Disintegrating Tablets, USP, 1 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-309-02 (carton), NDC #: 49884-309-52 (blisters).

by ENDO USA, Inc.

Reason: Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Published: January 15, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

Clonazepam Orally Disintegrating Tablets, USP, 0.25 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-307-02 (carton), NDC #: 49884-307-52 (blisters).

by ENDO USA, Inc.

Reason: Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Published: January 15, 2025
Distribution: Nationwide

View recall →

Data last updated: September 9, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.